Trial intelligence / Profile preview

Phase 3 study of turoctocog alfa pegol in males (Japan)

jRCT2080222169Phase 3Completed

Start
Aug 2013
Modality
Recombinant Proteins and Enzymes
01

Overview

Phase 3 trial of octocog alfa in hemophilia A. Started Aug 2013; status: completed.

02

Drugs

octocog alfa
03

Conditions

hemophilia A

Beyond the preview

Go deeper on jRCT2080222169.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080222169.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call